229 related articles for article (PubMed ID: 21830119)
1. Transglutaminase 2 is secreted from smooth muscle cells by transamidation-dependent microparticle formation.
van den Akker J; van Weert A; Afink G; Bakker EN; van der Pol E; Böing AN; Nieuwland R; VanBavel E
Amino Acids; 2012 Feb; 42(2-3):961-73. PubMed ID: 21830119
[TBL] [Abstract][Full Text] [Related]
2. External GTP-bound transglutaminase 2 is a molecular switch for chondrocyte hypertrophic differentiation and calcification.
Johnson KA; Terkeltaub RA
J Biol Chem; 2005 Apr; 280(15):15004-12. PubMed ID: 15691824
[TBL] [Abstract][Full Text] [Related]
3. Transglutaminase 2 in pulmonary and cardiac tissue remodeling in experimental pulmonary hypertension.
Penumatsa KC; Toksoz D; Warburton RR; Kharnaf M; Preston IR; Kapur NK; Khosla C; Hill NS; Fanburg BL
Am J Physiol Lung Cell Mol Physiol; 2017 Nov; 313(5):L752-L762. PubMed ID: 28775095
[TBL] [Abstract][Full Text] [Related]
4. Characterization of Transglutaminase 2 activity inhibitors in monocytes in vitro and their effect in a mouse model for multiple sclerosis.
Chrobok NL; Bol JGJM; Jongenelen CA; Brevé JJP; El Alaoui S; Wilhelmus MMM; Drukarch B; van Dam AM
PLoS One; 2018; 13(4):e0196433. PubMed ID: 29689097
[TBL] [Abstract][Full Text] [Related]
5. Transglutaminase 2 strongly binds to an extracellular matrix component other than fibronectin via its second C-terminal beta-barrel domain.
Stamnaes J; Cardoso I; Iversen R; Sollid LM
FEBS J; 2016 Nov; 283(21):3994-4010. PubMed ID: 27685605
[TBL] [Abstract][Full Text] [Related]
6. Activation of extracellular transglutaminase 2 by mechanical force in the arterial wall.
Huelsz-Prince G; Belkin AM; VanBavel E; Bakker EN
J Vasc Res; 2013; 50(5):383-95. PubMed ID: 23988702
[TBL] [Abstract][Full Text] [Related]
7. Transglutaminase 2 as a novel activator of LRP6/β-catenin signaling.
Deasey S; Nurminsky D; Shanmugasundaram S; Lima F; Nurminskaya M
Cell Signal; 2013 Dec; 25(12):2646-51. PubMed ID: 23993960
[TBL] [Abstract][Full Text] [Related]
8. A novel extracellular role for tissue transglutaminase in matrix-bound VEGF-mediated angiogenesis.
Wang Z; Perez M; Caja S; Melino G; Johnson TS; Lindfors K; Griffin M
Cell Death Dis; 2013 Sep; 4(9):e808. PubMed ID: 24052076
[TBL] [Abstract][Full Text] [Related]
9. The redox state of transglutaminase 2 controls arterial remodeling.
van den Akker J; VanBavel E; van Geel R; Matlung HL; Guvenc Tuna B; Janssen GM; van Veelen PA; Boelens WC; De Mey JG; Bakker EN
PLoS One; 2011; 6(8):e23067. PubMed ID: 21901120
[TBL] [Abstract][Full Text] [Related]
10. Tissue transglutaminase in astrocytes is enhanced by inflammatory mediators and is involved in the formation of fibronectin fibril-like structures.
Espitia Pinzón N; Brevé JJP; Bol JGJM; Drukarch B; Baron W; van Dam AM
J Neuroinflammation; 2017 Dec; 14(1):260. PubMed ID: 29282083
[TBL] [Abstract][Full Text] [Related]
11. Intracellular localization and conformational state of transglutaminase 2: implications for cell death.
Gundemir S; Johnson GV
PLoS One; 2009 Jul; 4(7):e6123. PubMed ID: 19568436
[TBL] [Abstract][Full Text] [Related]
12. Transglutaminase 2 inhibitor, KCC009, disrupts fibronectin assembly in the extracellular matrix and sensitizes orthotopic glioblastomas to chemotherapy.
Yuan L; Siegel M; Choi K; Khosla C; Miller CR; Jackson EN; Piwnica-Worms D; Rich KM
Oncogene; 2007 Apr; 26(18):2563-73. PubMed ID: 17099729
[TBL] [Abstract][Full Text] [Related]
13. Transglutaminase-2 interaction with heparin: identification of a heparin binding site that regulates cell adhesion to fibronectin-transglutaminase-2 matrix.
Lortat-Jacob H; Burhan I; Scarpellini A; Thomas A; Imberty A; Vivès RR; Johnson T; Gutierrez A; Verderio EA
J Biol Chem; 2012 May; 287(22):18005-17. PubMed ID: 22442151
[TBL] [Abstract][Full Text] [Related]
14. Functional characterization of naturally occurring transglutaminase 2 mutants implicated in early-onset type 2 diabetes.
Salter NW; Ande SR; Nguyen HK; Nyomba BL; Mishra S
J Mol Endocrinol; 2012 Jun; 48(3):203-16. PubMed ID: 22394545
[TBL] [Abstract][Full Text] [Related]
15. β
Vyas FS; Nelson CP; Freeman F; Boocock DJ; Hargreaves AJ; Dickenson JM
Eur J Pharmacol; 2017 Oct; 813():105-121. PubMed ID: 28754379
[TBL] [Abstract][Full Text] [Related]
16. Transglutaminase 2 is central to induction of the arterial calcification program by smooth muscle cells.
Johnson KA; Polewski M; Terkeltaub RA
Circ Res; 2008 Mar; 102(5):529-37. PubMed ID: 18202319
[TBL] [Abstract][Full Text] [Related]
17. Transglutaminase 2: a multi-functional protein in multiple subcellular compartments.
Park D; Choi SS; Ha KS
Amino Acids; 2010 Aug; 39(3):619-31. PubMed ID: 20148342
[TBL] [Abstract][Full Text] [Related]
18. Identification of DNAJA1 as a novel interacting partner and a substrate of human transglutaminase 2.
Ergülen E; Bécsi B; Csomós I; Fésüs L; Kanchan K
Biochem J; 2016 Nov; 473(21):3889-3901. PubMed ID: 27551108
[TBL] [Abstract][Full Text] [Related]
19. Astrocyte-derived tissue transglutaminase interacts with fibronectin: a role in astrocyte adhesion and migration?
van Strien ME; Brevé JJ; Fratantoni S; Schreurs MW; Bol JG; Jongenelen CA; Drukarch B; van Dam AM
PLoS One; 2011; 6(9):e25037. PubMed ID: 21949843
[TBL] [Abstract][Full Text] [Related]
20. Endoplasmic reticulum-resident protein 57 (ERp57) oxidatively inactivates human transglutaminase 2.
Yi MC; Melkonian AV; Ousey JA; Khosla C
J Biol Chem; 2018 Feb; 293(8):2640-2649. PubMed ID: 29305423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]